Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP1 fragment

Modification of chromatin and related transcription factors by histone deacetylases (HDACs) is one of the major strategies for controlling gene expression in eukaryotes. The HDAC domains of class IIa HDACs repress the respective target genes by interacting with the C-terminal region of the silencing mediator for retinoid and thyroid receptor (SMRT) repression domain 3 (SRD3c). However, latent catalytic activity suggests that their roles as deacetylases in gene regulation are unclear. Here, we found that two conserved GSI-containing motifs of SRD3c are critical for HDAC4 binding. Two SMRT peptides including these motifs commonly form a β-hairpin structure in the cleft and block the catalytic entry site of HDAC4. They interact mainly with class IIa HDAC-specific residues of HDAC4 in a closed conformation. Structure-guided mutagenesis confirmed critical interactions between the SMRT peptides and HDAC4 and -5 as well as the contribution of the Arg1369 residue in the first motif for optimal binding to the two HDACs. These results indicate that SMRT binding does not activate the cryptic deacetylase activity of HDAC4 and explain how class IIa HDACs and the SMRT-HDAC3 complex are coordinated during gene regulation.

[1]  R. Yao,et al.  Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21. , 2018, Experimental hematology.

[2]  Jeffrey J. Gray,et al.  Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors , 2018, Nature Communications.

[3]  S. Hsu,et al.  Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma , 2018, Cancers.

[4]  M. Blackledge,et al.  Structural Characterization of the SMRT Corepressor Interacting with Histone Deacetylase 7 , 2017, Scientific Reports.

[5]  Jeong-Sun Kim,et al.  Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and -5 as the Major Binding Surface of SMRT Corepressor , 2015, PloS one.

[6]  J. Schwabe,et al.  Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex , 2015, The Journal of Biological Chemistry.

[7]  A. Hekmatdoost,et al.  The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review. , 2015, Gene.

[8]  H. Kook,et al.  Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy , 2015, BMB reports.

[9]  R. Bürli,et al.  Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. , 2013, Journal of medicinal chemistry.

[10]  J. Schwabe,et al.  Structure of HDAC3 bound to corepressor and inositol tetraphosphate , 2011, Nature.

[11]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[12]  Maud Martin,et al.  Class IIa histone deacetylases: conducting development and differentiation. , 2009, The International journal of developmental biology.

[13]  L. Thompson,et al.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders , 2008, Nature Reviews Drug Discovery.

[14]  M. Bottomley,et al.  Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain* , 2008, Journal of Biological Chemistry.

[15]  S. Vatner,et al.  A Redox-Dependent Pathway for Regulating Class II HDACs and Cardiac Hypertrophy , 2008, Cell.

[16]  J. Min,et al.  Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity* , 2008, Journal of Biological Chemistry.

[17]  U. Koch,et al.  Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases , 2007, Proceedings of the National Academy of Sciences.

[18]  Ji Young Kim,et al.  One- plus Two-hybrid System, a Novel Yeast Genetic Selection for Specific Missense Mutations Disrupting Protein/Protein Interactions* , 2007, Molecular & Cellular Proteomics.

[19]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[20]  S. Berger The complex language of chromatin regulation during transcription , 2007, Nature.

[21]  M. Lazar,et al.  Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Caraglia,et al.  Acetylation of proteins as novel target for antitumor therapy: Review article , 2004, Amino Acids.

[23]  F. Dequiedt,et al.  Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo * , 2001, The Journal of Biological Chemistry.

[24]  Xiang-Jiao Yang,et al.  Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals , 2001, Molecular and Cellular Biology.

[25]  E. Olson,et al.  Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases , 2001, Molecular and Cellular Biology.

[26]  M. Guenther,et al.  The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3 , 2001, Molecular and Cellular Biology.

[27]  E. Olson,et al.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation , 2000, Nature.

[28]  E. Miska,et al.  Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. , 2000, Genes & development.

[29]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[30]  P. D. de Jong,et al.  Ligation-independent cloning of PCR products (LIC-PCR). , 1990, Nucleic acids research.

[31]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[32]  F. Dequiedt,et al.  Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. , 2002, Molecular cell.